Circulation, Vol 81, 850-859, Copyright © 1990 by American Heart Association
EG Nabel, AP Selwyn and P Ganz
Vasodilation in normal and vasoconstriction in atherosclerotic coronary
arteries have been observed in response to complex stimuli such as exercise
and the cold pressor test. To study a single parameter that changes during
these activities, and to better understand the pathophysiology of ischemia
associated with increases in heart rate, we studied coronary vasomotion and
blood flow response to increasing heart rate alone, produced by atrial
pacing, with quantitative angiographic and Doppler flow-velocity
measurements in 15 patients. In five patients with angiographically smooth
coronary arteries (group 1), tachycardia produced progressive dilation of
the epicardial artery with increases in cross-sectional area (CSA) of +15.5
+/- 3.4%, +22.4 +/- 2.1%, +28.5 +/- 3.3%, and +30.6 +/- 2.2% at 90, 110,
130, and 150 beats/min, respectively. In contrast, in five patients with
mild angiographic narrowings (group 2), coronary segments failed to dilate
with progressive tachycardia (-6.3 +/- 2.0%, -8.3 +/- 2.0%, -12.5 +/- 2.0%,
and -11.4% at 90, 110, 130, and 150 beats/min, respectively), and
progressive loss of luminal area was observed in five patients with severe
angiographic narrowings (group 3) (-34.4 +/- 3.4%, -49.6 +/- 2.2%, -59.2%,
and -72.8% at 90, 110, 130, and 150 beats/min, respectively). Coronary
blood flow increased significantly with tachycardia in group 1 (+44.5 +/-
10.2%, +86.0 +/- 24.6%, +105.8 +/- 29.3%, and +137.5 +/- 46.0%), increased
slightly in group 2 (+7.8 +/- 3.2%, +9.4 +/- 4.4%, +8.4 +/- 3.9%, and
+10.0%), and decreased significantly in group 3 (-31.8 +/- 6%, -42.6 +/-
10.7%, -61.0%, and - 70.0%). We conclude that an isolated increase in heart
rate in patients with normal coronary arteries results in a modest increase
in flow and vasodilation. In early atherosclerosis, the flow increase is
blunted and dilation is replaced with paradoxical loss in luminal size. In
patients with stenoses, further loss in luminal size occurs accompanied by
a decrease in coronary blood flow. Thus, increasing heart rate alone in the
setting of coronary stenoses could produce myocardial ischemia by a
reduction in coronary supply, as well as by an increase in oxygen demand.
ARTICLES
Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
This article has been cited by other articles:
![]() |
M. I. Hamilos, M. Ostojic, B. Beleslin, D. Sagic, L. Mangovski, S. Stojkovic, M. Nedeljkovic, D. Orlic, B. Milosavljevic, D. Topic, et al. Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion. J. Am. Coll. Cardiol., June 3, 2008; 51(22): 2123 - 2129. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kusmic, G. Lazzerini, F. Coceani, R. Barsacchi, A. L'Abbate, and G. Sambuceti Paradoxical coronary microcirculatory constriction during ischemia: a synergic function for nitric oxide and endothelin Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1814 - H1821. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sambuceti, M. Marzilli, A. Mari, C. Marini, M. Schluter, R. Testa, M. Papini, P. Marraccini, G. Ciriello, P. Marzullo, et al. Coronary microcirculatory vasoconstriction is heterogeneously distributed in acutely ischemic myocardium Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2298 - H2305. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Jadhav, J Petrie, W Ferrell, S Cobbe, and N Sattar Insulin resistance as a contributor to myocardial ischaemia independent of obstructive coronary atheroma: a role for insulin sensitisation? Heart, December 1, 2004; 90(12): 1379 - 1383. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Priebe Triggers of perioperative myocardial ischaemia and infarction Br. J. Anaesth., July 1, 2004; 93(1): 9 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Barbato, J. Bartunek, E. Wyffels, W. Wijns, G. R. Heyndrickx, and B. De Bruyne Effects of intravenous dobutamineon coronary vasomotion in humans J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1596 - 1601. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Kern Dobutamine and the coronary vasomotion paradox J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1602 - 1604. [Full Text] [PDF] |
||||
![]() |
D Tousoulis, G J Davies, C Tentolouris, T Crake, G Goumas, C Stefanadis, and P Toutouzas Effects of L-arginine on flow mediated dilatation induced by atrial pacing in diseased epicardial coronary arteries Heart, May 1, 2003; 89(5): 531 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. J. Halcox, K. R. A. Nour, G. Zalos, R. Mincemoyer, M. A. Waclawiw, C. E. Rivera, G. Willie, S. Ellahham, and A. A. Quyyumi The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1232 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Al-Bustami, M. Amrani, A. H. Chester, C. J. Ilsley, and M. H. Yacoub In vivo early and mid-termflow-mediated endothelial functionof the radial artery used as a coronary bypass graft J. Am. Coll. Cardiol., February 20, 2002; 39(4): 573 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zaugg, M. C. Schaub, T. Pasch, and D. R. Spahn Modulation of {beta}-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action Br. J. Anaesth., January 1, 2002; 88(1): 101 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. De Bruyne, F. Hersbach, N. H.J. Pijls, J. Bartunek, J.-W. Bech, G. R. Heyndrickx, K. L. Gould, and W. Wijns Abnormal Epicardial Coronary Resistance in Patients With Diffuse Atherosclerosis but "Normal" Coronary Angiography Circulation, November 13, 2001; 104(20): 2401 - 2406. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Prasad, J. P. J. Halcox, M. A. Waclawiw, and A. A. Quyyumi Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1089 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kinlay, D. Behrendt, M. Wainstein, J. Beltrame, J. C. Fang, M. A. Creager, A. P. Selwyn, and P. Ganz Role of Endothelin-1 in the Active Constriction of Human Atherosclerotic Coronary Arteries Circulation, September 4, 2001; 104(10): 1114 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Landesberg, M. Mosseri, D. Zahger, Y. Wolf, M. Perouansky, H. Anner, B. Drenger, Y. Hasin, Y. Berlatzky, and C. Weissman Myocardial infarction after vascular surgery: the role of prolonged, stress-induced, ST depression-type ischemia J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1839 - 1845. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sambuceti, M. Marzilli, S. Fedele, C. Marini, and A. L'Abbate Paradoxical Increase in Microvascular Resistance During Tachycardia Downstream From a Severe Stenosis in Patients With Coronary Artery Disease : Reversal by Angioplasty Circulation, May 15, 2001; 103(19): 2352 - 2360. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nitenberg, S. Ledoux, P. Valensi, R. Sachs, J.-R. Attali, and I. Antony Impairment of Coronary Microvascular Dilation in Response to Cold Pressor-Induced Sympathetic Stimulation in Type 2 Diabetic Patients With Abnormal Stress Thallium Imaging Diabetes, May 1, 2001; 50(5): 1180 - 1185. [Abstract] [Full Text] |
||||
![]() |
W. J. Kop, D. S. Krantz, R. H. Howell, M. A. Ferguson, V. Papademetriou, D. Lu, J. J. Popma, J. F. Quigley, M. Vernalis, and J. S. Gottdiener Effects of mental stress on coronary epicardial vasomotion and flow velocity in coronary artery disease: relationship with hemodynamic stress responses J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1359 - 1366. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sambuceti, A. L'Abbate, and M. Marzilli Why should we study the coronary microcirculation? Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2581 - H2584. [Full Text] [PDF] |
||||
![]() |
T. Tanikawa, H. Kanatsuka, R. Koshida, M. Tanaka, A. Sugimura, T. Kumagai, M. Miura, T. Komaru, and K. Shirato Role of pertussis toxin-sensitive G protein in metabolic vasodilation of coronary microcirculation Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1819 - H1829. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. KINGWELL Nitric oxide-mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease FASEB J, September 1, 2000; 14(12): 1685 - 1696. [Abstract] [Full Text] |
||||
![]() |
A P Mansur, C V Serrano Jr, J C Nicolau, L A M César, and J A F Ramires Effect of cholesterol lowering treatment on positive exercise tests in patients with hypercholesterolaemia and normal coronary angiograms Heart, December 1, 1999; 82(6): 689 - 693. [Abstract] [Full Text] |
||||
![]() |
C. A. Schneider, E. Voth, D. Moka, F. M. Baer, J. Melin, A. Bol, R. Wagner, H. Schicha, E. Erdmann, and U. Sechtem Improvement of myocardial blood flow to ischemic regions by angiotensin- converting enzyme inhibition with quinaprilat IV: A study using [15O] water dobutamine stress positron emission tomography J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1005 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
O Gurne, P Chenu, M Buche, Y Louagie, P Eucher, B Marchandise, E Rombaut, D Blommaert, and E Schroeder Adaptive mechanisms of arterial and venous coronary bypass grafts to an increase in flow demand Heart, September 1, 1999; 82(3): 336 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Prasad, S. Husain, and A. A. Quyyumi Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: A potential role of bradykinin J. Am. Coll. Cardiol., March 1, 1999; 33(3): 796 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Kal, I. Vergroesen, and H. B. van Wezel The Effect of Nitroglycerin on Pacing-Induced Changes in Myocardial Oxygen Consumption and Metabolic Coronary Vasodilation in Patients with Coronary Artery Disease Anesth. Analg., February 1, 1999; 88(2): 271 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Quyyumi Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia?: A double-blind comparison of parenteral D- and L-Arginine J. Am. Coll. Cardiol., October 1, 1998; 32(4): 904 - 911. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Makita, M. Nakamura, A. Ohira, S. Ito, K. Yoshioka, A. Hirose, T. Nakajima, K. Komoda, K. Kawazoe, and K. Hiramori Impaired Peripheral Vasodilation in Ischemic and Nonischemic Limbs of Patients with Unilateral Arteriosclerosis Obliterans: Effect of Revascularization on Leg Hemodynamics Vascular and Endovascular Surgery, September 1, 1998; 32(5): 491 - 502. [Abstract] [PDF] |
||||
![]() |
R. O. Cannon III Role of nitric oxide in cardiovascular disease: focus on the endothelium Clin. Chem., August 1, 1998; 44(8): 1809 - 1819. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Baliga, S. D. Rosen, P. G. Camici, and J. S. Kooner Regional Myocardial Blood Flow Redistribution as a Cause of Postprandial Angina Pectoris Circulation, March 31, 1998; 97(12): 1144 - 1149. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sambuceti, M. Marzilli, P. Marraccini, J. Schneider-Eicke, E. Gliozheni, O. Parodi, and A. L'Abbate Coronary Vasoconstriction During Myocardial Ischemia Induced by Rises in Metabolic Demand in Patients With Coronary Artery Disease Circulation, June 17, 1997; 95(12): 2652 - 2659. [Abstract] [Full Text] |
||||
![]() |
K. Egashira, Y. Katsuda, M. Mohri, T. Kuga, T. Tagawa, T. Kubota, Y. Hirakawa, and A. Takeshita Role of Endothelium-Derived Nitric Oxide in Coronary Vasodilatation Induced by Pacing Tachycardia in Humans Circ. Res., August 1, 1996; 79(2): 331 - 335. [Abstract] [Full Text] |
||||
![]() |
P. N. Petropoulakis, M. K. Kyriakidis, C. A. Tentolouris, C. V. Kourouclis, and P. K. Toutouzas Changes in Phasic Coronary Blood Flow Velocity Profile in Relation to Changes in Hemodynamic Parameters During Stress in Patients With Aortic Valve Stenosis Circulation, September 15, 1995; 92(6): 1437 - 1447. [Abstract] [Full Text] |
||||
![]() |
A. A. Quyyumi, N. Dakak, N. P. Andrews, D. M. Gilligan, J. A. Panza, and R. O. Cannon III Contribution of Nitric Oxide to Metabolic Coronary Vasodilation in the Human Heart Circulation, August 1, 1995; 92(3): 320 - 326. [Abstract] [Full Text] |
||||
![]() |
G. Ferro, C. Duilio, L. Spinelli, G. A. Liucci, F. Mazza, and C. Indolfi Relation Between Diastolic Perfusion Time and Coronary Artery Stenosis During Stress-Induced Myocardial Ischemia Circulation, August 1, 1995; 92(3): 342 - 347. [Abstract] [Full Text] |
||||
![]() |
L. Kuo, M. J. Davis, and W. M. Chilian Longitudinal Gradients for Endothelium-Dependent and -Independent Vascular Responses in the Coronary Microcirculation Circulation, August 1, 1995; 92(3): 518 - 525. [Abstract] [Full Text] |
||||
![]() |
A. M. Zeiher, T. Krause, V. Schachinger, J. Minners, and E. Moser Impaired Endothelium-Dependent Vasodilation of Coronary Resistance Vessels Is Associated With Exercise-Induced Myocardial Ischemia Circulation, May 1, 1995; 91(9): 2345 - 2352. [Abstract] [Full Text] |
||||
![]() |
G. N. Levine, J. F. Keaney, and J. A. Vita Cholesterol Reduction in Cardiovascular Disease -- Clinical Benefits and Possible Mechanisms N. Engl. J. Med., February 23, 1995; 332(8): 512 - 521. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1990 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |